Immunovant, Inc.
← Back to IMVT Overview

Immunovant, Inc. (IMVT)

Solvency & Capital Structure

Total Debt

$72K

Net Debt

-$902M

Immunovant, Inc. currently has $72K in total debt. Net debt is -$902M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

IMVTQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.000.90-0.90Net Cash0.960.0%
2025-12-310.000.99-0.99Net Cash1.050.0%
2025-09-300.000.52-0.52Net Cash0.580.0%
2025-06-300.000.60-0.60Net Cash0.660.0%
2025-03-310.000.71-0.71Net Cash0.780.0%
2024-12-310.000.37-0.37Net Cash0.420.0%
2024-09-300.000.47-0.47Net Cash0.520.0%
2024-06-300.000.56-0.56Net Cash0.590.0%
2024-03-310.000.64-0.64Net Cash0.670.0%
2023-12-310.000.69-0.69Net Cash0.710.0%
2023-09-300.000.27-0.27Net Cash0.290.2%
2023-06-300.000.33-0.33Net Cash0.350.3%
2023-03-310.000.38-0.38Net Cash0.410.3%
2022-12-310.000.43-0.43Net Cash0.460.3%
2022-09-300.000.41-0.40Net Cash0.430.4%
2022-06-300.000.43-0.43Net Cash0.460.5%
2022-03-310.000.49-0.49Net Cash0.520.5%
2021-12-310.000.53-0.52Net Cash0.540.5%
2021-09-300.000.56-0.56Net Cash0.570.5%
2021-06-300.000.38-0.38Net Cash0.390.8%
2021-03-310.000.40-0.40Net Cash0.410.8%
2020-12-310.000.42-0.42Net Cash0.430.8%
2020-09-300.000.44-0.44Net Cash0.450.8%
2020-06-300.000.28-0.28Net Cash0.291.4%
2020-03-310.000.10-0.10Net Cash0.112.9%
2019-12-310.000.12-0.12Net Cash0.132.3%
2019-09-300.000.00-0.00Net Cash0.120.0%
2019-06-300.000.00-0.00Net Cash0.120.0%
2019-03-310.000.000.000.0092.4%
2018-06-300.000.000.000.00